보훈의학연구소 |
*서제현, *이영 |
Genes |
Causal Association between Iritis or Uveitis and Glaucoma: A Two-Sample Mendelian Randomisation Study, 2023 Mar 3;14(3):642. |
4.141 |
보훈의학연구소, 혈액종양내과 |
*배희원, **임태규, 길제령, 이문형 |
Liver Cancer |
Long-Term Regression after Discontinuation of Regorafenib Administered for Sorafenib-Refractory Hepatocellular Carcinoma, 2023 May 30;12(2):184-187. |
12.430 |
보훈의학연구소, 신경과, 핵의학과 |
*배희원, **강민주, 유장 |
International journal of molecular sciences |
Double Mutations in a Patient with Early-Onset Alzheimer's Disease in Korea: An APP Val551Met and a PSEN2 His169Asn, 2023 Apr 18;24(8):7446 |
6.208 |
보훈의학연구소 |
*권승현, **김학수 |
Journal of ginseng research |
Proteomic analysis for the effects of non-saponin fraction with rich polysaccharide from Korean Red Ginseng on Alzheimer's disease in a mouse model, 2023 Mar;47(2):302-310. |
5.735 |
내분비내과, 보훈의학연구소 |
*김예안, **서제현, 권승현, 이영 |
Investigative Ophthalmology & Visual Science |
Vitreous Fatty Amides and Acyl Carnitines Are Altered in Intermediate Age-Related Macular Degeneration, 2023 Mar 1;64(3):28. |
4.925 |
혈액종양내과 |
김해수 |
Journal of thoracic oncology |
A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21), 2023 Feb;18(2):223-231. |
20.121 |
정신건강의학과 |
이은영 |
European Journal of Clinical Nutrition |
The effect of proto-type wearable light-emitting devices on serum 25-hydroxyvitamin D levels in healthy adults: a 4-week randomized controlled trial, 2023 Mar;77(3):342-347. |
4.884 |
정형외과 |
*윤정로, **이승훈, 고영윤 |
Journal of orthopaedic surgery and research |
Estimation of the proper gap ratio using preoperative radiography for posterior tibial slope maintenance in biplanar open wedge high tibial osteotomy, 2023 Mar 20;18(1):219. |
2.677 |
핵의학과 |
*유장, 천미주 |
Cancers |
Radiomics Analysis of 18F-FDG PET/CT for Prognosis Prediction in Patients with Stage III Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiation Therapy Followed by Surgery, 2023 Mar 28;15(7):2012. |
6.575 |
감염내과 |
함신영, 이승재 |
J Korean Med Sci |
Short-Term Effectiveness of Oral Nirmatrelvir/Ritonavir Against the SARS-CoV-2 Omicron Variant and Culture-Positive Viral Shedding, 2023 Feb 27;38(8):e59. |
5.354 |